Hypoxia and other adverse conditions are commonly encountered by rapidly growing cells. The RNA-binding protein RBM3 (RNA-binding motif protein 3), which is transcriptionally induced by low temperature and hypoxia, has recently been implicated in survival of colon cancer cells by mechanisms involving cyclooxygenase-2 (COX-2) signaling. Immunohistochemically, we found strong RBM3 expression in a variety of malignant and proliferating tissues but low expression in resting and terminally differentiated cells. RBM3 expression in fibroblasts and human embryonal kidney (HEK293) cells subjected to serum deprivation or contact inhibition closely paralleled proliferation rates, assessed by real-time RT-PCR and immunoblotting. siRNA-mediated RBM3 knockdown reduced cell viability and finally led to cell death, which did not involve caspase-3-mediated apoptosis, cell cycle arrest, or COX-2 regulation. In contrast, RBM3 over-expression rescued cells from death under serum starvation. This was associated with increased translation rates, as measured by 14 C serine and 3 H phenylalanine incorporation. Together, RBM3 is a critical factor providing cellular survival advantages in an adverse microenvironment presumably by restoring translation efficacy. We have previously demonstrated that both RBM3 mRNA and protein levels increase in response to hypoxia in a hypoxia inducible factor (HIF)-1-independent fashion (2). RBM3 is also one of the first proteins synthesized in response to cold shock (3,4) and consistently elevated during winter in hibernating animals, such as the ground squirrel (5).An involvement of RBM3 in the regulation of translation has been deduced from increased rates of protein synthesis associated with its over-expression in transfected cells or RBM3 up-regulation after hypothermia (6). Over-expression of RBM3 has also been shown to suppress cell death in cells harboring polyglutamine-huntingtin (7) and to stabilize cyclooxygenase-2 (COX-2) mRNA transcripts (8). Moreover, RBM3 was found to prevent cells from caspase-mediated apoptosis and mitotic catastrophe (9). On the other hand, down-regulation of RBM3 in human colon cancer cells has been reported to cause loss of COX-2 translation and decrease cell growth in culture, which was partially overcome with the COX-2 product, prostaglandin E2 (9).Here, we set out to further characterize the link between RBM3, cell proliferation, and apoptosis. We found that RBM3 expression paralleled proliferation rates in vitro and in vivo. Over-expression of RBM3 rescued human embryonal kidney (HEK293) cells from cell death triggered by serum starvation, and siRNA-mediated RBM3 knockdown-induced cell death occurred without caspase-3 activation. Both artificial up-and down-regulation of RBM3 in HEK293 cells had no effect on COX-2 expression, indicating that other mechanisms are involved that improve cell survival especially under adverse conditions.
MATERIALS AND METHODSCell lines, lymphocyte preparation, culture conditions, and treatment.